SOMATIC 2 MASTR Plus and QC Plex Product Release

SOMATIC 2 MASTR Plus and QC Plex Product Release

March 24, 2015

Multiplicom is pleased to introduce the SOMATIC 2 MASTR™ Plus, a research use only assay, for sequencing analysis of genes involved in pathways of solid tumors formation. The SOMATIC 2 MASTR Plus is provided as a ready to use assay in three multiplex PCR reactions for the identification of mutations in the complete coding regions of the EGFR, ERBB2, PIK3CA, PIK3R1 and PTEN genes.

In addition, the QC Plex assay was released for quality assessment and integrity of FFPE-derived DNA samples. Together with the web-based DQC calculator (http://www.multiplicom.com/dqccalculator), the QC Plex ensures reliable amplification and reproducible results from SOMATIC 2 MASTR 2 plus when using DNA derived from solid tumors.

Enrich and detect CTCs of prostate cancer from blood

Enrich and detect CTCs of prostate cancer from blood

Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. In prostate cancer, the expression of three tumor-associated transcripts, prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA) and epidermal growth factor receptor (EGFR), are often altered and used as biomarkers.

March 01, 2017 More +
BRCA Tumor MASTR Plus Product launch

BRCA Tumor MASTR Plus Product launch

Multiplicom is pleased to announce the release of the BRCA Tumor MASTR Plus molecular assay, research use only, for identification of SNVs in the coding region of BRCA1 and BRCA2 in various types of solid tumors.

June 17, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us